A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Clinical trial NCT00141297 · COMPLETED

Trial details

NCT number: NCT00141297
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Lymphoma, Non-Hodgkin

Start date: 2004-09-01
Primary completion: 2008-07-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.